These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interventions to prevent surgical site infection in adults undergoing cardiac surgery. ; Rogers LJ; Vaja R; Bleetman D; Ali JM; Rochon M; Sanders J; Tanner J; Lamagni TL; Talukder S; Quijano-Campos JC; Lai F; Loubani M; Murphy GJ Cochrane Database Syst Rev; 2024 Dec; 12(12):CD013332. PubMed ID: 39620424 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
7. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
8. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
9. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
10. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
12. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
13. Strategies to improve smoking cessation rates in primary care. Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994 [TBL] [Abstract][Full Text] [Related]
14. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Palmer MJ; Henschke N; Bergman H; Villanueva G; Maayan N; Tamrat T; Mehl GL; Glenton C; Lewin S; Fønhus MS; Free C Cochrane Database Syst Rev; 2020 Jul; 8(8):CD013679. PubMed ID: 32813276 [TBL] [Abstract][Full Text] [Related]
15. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial. Marcovitz D; Dear ML; Donald R; Edwards DA; Kast KA; Le TDV; Shah MV; Ferrell J; Gatto C; Hennessy C; Buie R; Rice TW; Sullivan W; White KD; Van Winkle G; Wolf R; Lindsell CJ; JAMA Netw Open; 2024 Feb; 7(2):e2356430. PubMed ID: 38411964 [TBL] [Abstract][Full Text] [Related]
16. The Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program implementation strategy for expanding treatment for hospitalized adults with opioid use disorder. Moriates C; Boulton A; Bottner R; Weems J; Christian N; Bazajou T; Olmos DI; Bolton CD; Karns-Wright TE; Lanham HJ; Finley EP; Potter JS J Subst Use Addict Treat; 2025 Jan; 168():209539. PubMed ID: 39395756 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
18. Relationship of hub and treatment characteristics with client outcomes in the initial Washington State hub and spoke cohort. Reif S; Stewart MT; Daily SM; Brolin MF; Lee MT; Panas L; Ritter G; Shields MC; Mazel SB; Wicks JJ J Subst Use Addict Treat; 2025 Jan; 168():209544. PubMed ID: 39437904 [TBL] [Abstract][Full Text] [Related]